4415 related articles for article (PubMed ID: 4331089)
1. In vitro detection of cytotoxic cellular immunity against tumor-specific antigens by a radioisotopic technique.
Jagarlamoody SM; Aust JC; Tew RH; McKhann CF
Proc Natl Acad Sci U S A; 1971 Jun; 68(6):1346-50. PubMed ID: 4331089
[TBL] [Abstract][Full Text] [Related]
2. Mediation of immune responses to tumor antigens in vitro by immune RNA.
Kern DH; Drogemuller CR; Pilch YH
Ann N Y Acad Sci; 1976; 276():278-302. PubMed ID: 1071964
[TBL] [Abstract][Full Text] [Related]
3. In vitro induction of tumor-specific immunity. I. Parameters of activation and cytotoxic reactivity of mouse lymphoid cells immunized in vitro against syngeneic and allogeneic plasma cell tumors.
Wagner H; Röllinghoff M
J Exp Med; 1973 Jul; 138(1):1-15. PubMed ID: 4541509
[TBL] [Abstract][Full Text] [Related]
4. Tumor-secific immunity to chemically induced tumors. Evidence for immunologic specificity and shared antigenicity in lymphocyte responses to soluble tumor antigens.
Frbes JT; Nakaw Y; Smith RT
J Exp Med; 1975 May; 141(5):1181-200. PubMed ID: 47896
[TBL] [Abstract][Full Text] [Related]
5. Specific anti-tumor responses by cultured immune spleen cells. II. Culture supernatants induce specific anti-tumor cytotoxicity by non-immune lymphoid cells in vitro.
Nelson K; Pollack SB; Hellström KE
Int J Cancer; 1975 Aug; 16(2):292-300. PubMed ID: 1150355
[TBL] [Abstract][Full Text] [Related]
6. Antigenic specificity of the cytolytic T lymphocyte (CTL) response to murine sarcoma virus-induced tumors. I. Preferential reactivity of in vitro generated secondary CTL with syngeneic tumor cells.
Plata F; Jongeneel V; Cerottini JC; Brunner KT
Eur J Immunol; 1976 Nov; 6(11):823-9. PubMed ID: 187429
[TBL] [Abstract][Full Text] [Related]
7. In vitro demonstration of cryosurgical augmentation of tumor immunity.
Faraci RP; Bagley DH; Marrone J; Beazley RM
Surgery; 1975 Mar; 77(3):433-8. PubMed ID: 1124499
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxic reactions of murine lymphoid cells studied with a tritiated proline microcytotoxicity test.
Shiku H; Bean MA; Old LJ; Oettgen HF
J Natl Cancer Inst; 1975 Feb; 54(2):415-25. PubMed ID: 1113324
[TBL] [Abstract][Full Text] [Related]
9. Comparative in vitro sensitivity of twom methylcholanthrene-induced murine sarcoma lines to humoral and cellular immune cytotoxicity.
Bataillon G; Pross H; Klein G
Int J Cancer; 1975 Aug; 16(2):255-65. PubMed ID: 1150353
[TBL] [Abstract][Full Text] [Related]
10. Membrane-associated antigen from the SV40-induced hamster fibrosarcoma, para-7. I. Role in immune complex formation and effector cell blockade.
Prather SO; Lausch RN
Int J Cancer; 1976 Dec; 18(6):820-8. PubMed ID: 62726
[TBL] [Abstract][Full Text] [Related]
11. Specificity of antitumor immune reactions mediated by xenogeneic immune RNA.
Kern DH; Drogemuller CR; Chow N; Holleman DD; Pilch YH
J Natl Cancer Inst; 1977 Jan; 58(1):117-21. PubMed ID: 833854
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of cell-mediated cytotoxicity against tumor-associated antigens by suppressor cells from tumor-bearing mice.
Glaser M; Kirchner H; Holden HT; Herberman RB
J Natl Cancer Inst; 1976 Apr; 56(4):865-7. PubMed ID: 1255803
[TBL] [Abstract][Full Text] [Related]
13. Specific depression of the antitumor cellular immune response with autologous tumor homogenate.
Paranjpe MS; Boone CW
Cancer Res; 1975 May; 35(5):1205-9. PubMed ID: 164281
[TBL] [Abstract][Full Text] [Related]
14. Serum-mediated protection of neoplastic cells from inhibition by lymphocytes immune to their tumor-specific antigens.
Hellström I; Hellström KE; Evans CA; Heppner GH; Pierce GE; Yang JP
Proc Natl Acad Sci U S A; 1969 Feb; 62(2):362-8. PubMed ID: 5256215
[TBL] [Abstract][Full Text] [Related]
15. The specificity of concomitant tumor immunity at large tumor volumes.
Deckers PJ; Pardridge DH; Wang BS; Mannick JA
Cancer Res; 1976 Oct; 36(10):3690-4. PubMed ID: 953994
[TBL] [Abstract][Full Text] [Related]
16. Cellular immunity to a common human sarcoma antigen and its specific inhibition by sera from patients with growing sarcomas.
Cohen AM; Ketcham AS; Morton DL
Surgery; 1972 Oct; 72(4):560-7. PubMed ID: 4506654
[No Abstract] [Full Text] [Related]
17. Cellular immune responses to methylcholanthrene-induced fibrosarcoma in BALB/c mice.
Bhatnagar RM; Zabriskie JB; Rausen AR
J Exp Med; 1975 Oct; 142(4):839-55. PubMed ID: 1185107
[TBL] [Abstract][Full Text] [Related]
18. Antibody production and interaction with lymphoid cells in relation to tumor immunity in the Moloney sarcoma virus system.
Harada M; Pearson G; Redmon L; Winters E; Kasuga S
J Immunol; 1975 Apr; 114(4):1318-22. PubMed ID: 1090675
[TBL] [Abstract][Full Text] [Related]
19. Mediation of cytotoxic immune responses against human tumor-associated antigens by allogeneic immune RNA.
Kern DH; Fritze D; Schick PM; Chow N; Pilch YH
J Natl Cancer Inst; 1976 Jul; 57(1):105-9. PubMed ID: 1003493
[TBL] [Abstract][Full Text] [Related]
20. The lymphocyte response to primary Moloney sarcoma virus tumors: definition of a non-specific component of the in vitro cellular hyporeactivity of tumor-bearing hosts.
Kiessling R; Bataillon G; Lamon EW; Klein E
Int J Cancer; 1974 Nov; 14(5):642-8. PubMed ID: 4459279
[No Abstract] [Full Text] [Related]
[Next] [New Search]
